McCarthy Caroline, Moynagh Patrick, Fahey Tom, Boland Fiona, Moriarty Frank
Department of General Practice, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin 2, Ireland.
Data Science Centre, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
Br J Clin Pharmacol. 2025 Apr;91(4):1241-1249. doi: 10.1111/bcp.16356. Epub 2024 Dec 8.
The Drug Utilization 90% Index (DU90%), the number of medicines making up 90% of a doctor's prescribing, is a simple tool that can be used to describe core prescribing patterns. This research aimed to pilot the application of the DU90% in the Irish context, to investigate the relationship between the DU90% and prescriber and practice characteristics and prescribing quality.
Retrospective observational study using anonymous prescription data from a sample of Irish general practitioners (GPs). Participating GPs provided demographic details and extracted prescription data for 2018-2022 using their existing software systems. The DU90% was calculated annually at both the practice and prescriber level. Prescribing quality indicators included antibiotic, benzodiazepine prescribing rates and high-risk nonsteroidal anti-inflammatory drug prescribing. The association of the DU90% with prescriber and practice characteristics and prescribing quality indicators was explored with multilevel modelling.
Thirty-eight prescribers from 22 different practices were included. The mean DU90% for prescribers was 141.5 (standard deviation 12.9) and for practices was 145.62 (standard deviation 11.87). Practices in receipt of the rural deprivation grant had a significantly lower DU90% (incidence rate ratio 0.94, 95% confidence interval 0.88-0.98). There was no evidence of an association between prescriber-level characteristics and the DU90% (sex, years qualified, number of sessions worked). There was a small positive relationship between the prescriber DU90% and total prescriptions, antibiotic and benzodiazepine prescribing rates, and higher rates of high-risk nonsteroidal anti-inflammatory drug prescriptions.
Applying the DU90% to Irish general practice prescriptions is feasible, revealing that GPs typically use 140 medicines in the bulk of their prescribing.
药物利用90%指数(DU90%),即构成医生处方量90%的药物数量,是一种可用于描述核心处方模式的简单工具。本研究旨在在爱尔兰背景下试行DU90%的应用,调查DU90%与开处方者、执业特征及处方质量之间的关系。
采用回顾性观察研究,使用来自爱尔兰全科医生(GP)样本的匿名处方数据。参与研究的全科医生提供人口统计学细节,并使用其现有软件系统提取2018 - 2022年的处方数据。每年在执业机构和开处方者层面计算DU90%。处方质量指标包括抗生素、苯二氮䓬类药物的处方率以及高风险非甾体抗炎药的处方情况。通过多水平模型探讨DU90%与开处方者、执业特征及处方质量指标之间的关联。
纳入了来自22个不同执业机构的38名开处方者。开处方者的平均DU90%为141.5(标准差12.9),执业机构的平均DU90%为145.62(标准差11.87)。获得农村贫困补助的执业机构的DU90%显著更低(发病率比0.94,95%置信区间0.88 - 0.98)。没有证据表明开处方者层面的特征(性别、执业年限、工作时长)与DU90%之间存在关联。开处方者的DU90%与总处方量、抗生素和苯二氮䓬类药物的处方率以及高风险非甾体抗炎药的较高处方率之间存在小的正相关关系。
将DU90%应用于爱尔兰全科医疗处方是可行的,这表明全科医生在大部分处方中通常使用140种药物。